International Network for Comparison of HIV Neutralization Assays: The NeutNet Report

Detalhes bibliográficos
Autor(a) principal: Fenyö, Eva Maria
Data de Publicação: 2009
Outros Autores: Heath, Alan, Dispinseri, Stefania, Holmes, Harvey, Lusso, Paolo, Zolla-Pazner, Susan, Donners, Helen, Heyndrickx, Leo, Alcami, Jose, Bongertz, Vera, Jassoy, Christian, Malnati, Mauro, Montefiori, David, Moog, Christiane, Morris, Lynn, Osmanov, Saladin, Polonis, Victoria, Sattentau, Quentin, Schuitemaker, Hanneke, Sutthent, Ruenpung, Wrin, Terri, Scarlatti, Gabriella
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/15808
Resumo: University of Lund. Department of Microbiology, Dermatology and Infection. Lund, Sweden.
id CRUZ_f17c1a05c353f7eb24d70ffa2aecc8cd
oai_identifier_str oai:www.arca.fiocruz.br:icict/15808
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Fenyö, Eva MariaHeath, AlanDispinseri, StefaniaHolmes, HarveyLusso, PaoloZolla-Pazner, SusanDonners, HelenHeyndrickx, LeoAlcami, JoseBongertz, VeraJassoy, ChristianMalnati, MauroMontefiori, DavidMoog, ChristianeMorris, LynnOsmanov, SaladinPolonis, VictoriaSattentau, QuentinSchuitemaker, HannekeSutthent, RuenpungWrin, TerriScarlatti, Gabriella2016-09-15T13:53:21Z2016-09-15T13:53:21Z2009FENYÖ, Eva Maria; et al. International Network for Comparison of HIV Neutralization Assays: The NeutNet Report. Plos One, v.4, n.2, e4505, 12p, Feb. 2009.1932-6203https://www.arca.fiocruz.br/handle/icict/1580810.1371/journal.pone.0004505engPublic Library of ScienceRede InternacionalEnsaios de neutralizaçãoHIVInternational NetworkThe Neutnet ReportHIV NeutralizationNeutralization assaysInternational Network for Comparison of HIV Neutralization Assays: The NeutNet Reportinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversity of Lund. Department of Microbiology, Dermatology and Infection. Lund, Sweden.National Institute for Biological Standards and Control. Potters Bar, Hertfordshire, United Kingdom.San Raffaele Scientific Institute. Viral Evolution and Transmission Unit. Milan, Italy.National Institute for Biological Standards and Control. Potters Bar, Hertfordshire, United Kingdom.San Raffaele Scientific Institute. Unit of Human Virology. Milan, Italy.New York University School of Medicine. New York, NY, USA.Institute of Tropical Medicine. Department of Microbiology. Virology Unit. Antwerp, Belgium.Institute of Tropical Medicine. Department of Microbiology. Virology Unit. Antwerp, Belgium.Instituto de Salud Carlos III. Unidad de Immunopatologia del SIDA. Madrid, Spain.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.University of Leipzig. Institute of Virology. Leipzig, Germany.San Raffaele Scientific Institute. Unit of Human Virology. Milan, Italy.Duke University Medical Center. Department of Surgery. Durham, NC, USA.University Louis Pasteur. Pathogénie des infections persistantes. Strasbourg, France.National Institute for Communicable Diseases. Johannesburg, South Africa.World Health Organization. WHO-UNAIDS HIV Vaccine Initiative (IVR/HVI). Geneva, Switzerland.Henry Jackson Foundation for the Advancement of Military Medicine. Department of Vaccine Research. Rockville, Maryland, USA.University of Oxford. Sir William Dunn School of Pathology. Oxford, United Kingdom.University of Amsterdam. Academic Medical Center. Department of Experimental Immunology. Sanquin Research. Landsteiner Laboratory. Center for Infectious Diseases and Immunity Amsterdam (CINIMA). Amsterdam, Netherlands.Mahidol University. Faculty of Microbiology. Siriraj Hospital .National HIV Repository and Bioinformatic Center. Bangkok, Thailand.Monogram Biosciences Inc. South San Francisco, CA, USA.San Raffaele Scientific Institute. Viral Evolution and Transmission Unit. Milan, Italy.Background: Neutralizing antibody assessments play a central role in human immunodeficiency virus type-1 (HIV-1) vaccine development but it is unclear which assay, or combination of assays, will provide reliable measures of correlates of protection. To address this, an international collaboration (NeutNet) involving 18 independent participants was organized to compare different assays. Methods: Each laboratory evaluated four neutralizing reagents (TriMab, 447-52D, 4E10, sCD4) at a given range of concentrations against a panel of 11 viruses representing a wide range of genetic subtypes and phenotypes. A total of 16 different assays were compared. The assays utilized either uncloned virus produced in peripheral blood mononuclear cells (PBMCs) (virus infectivity assays, VI assays), or their Env-pseudotyped (gp160) derivatives produced in 293T cells (PSV assays) from molecular clones or uncloned virus. Target cells included PBMC and genetically-engineered cell lines in either a singleor multiple-cycle infection format. Infection was quantified by using a range of assay read-outs that included extracellular or intracellular p24 antigen detection, RNA quantification and luciferase and beta-galactosidase reporter gene expression. Findings: PSV assays were generally more sensitive than VI assays, but there were important differences according to the virus and inhibitor used. For example, for TriMab, the mean IC50 was always lower in PSV than in VI assays. However, with 4E10 or sCD4 some viruses were neutralized with a lower IC50 in VI assays than in the PSV assays. Inter-laboratory concordance was slightly better for PSV than for VI assays with some viruses, but for other viruses agreement between laboratories was limited and depended on both the virus and the neutralizing reagent. Conclusions: The NeutNet project demonstrated clear differences in assay sensitivity that were dependent on both the neutralizing reagent and the virus. No single assay was capable of detecting the entire spectrum of neutralizing activities. Since it is not known which in vitro assay correlates with in vivo protection, a range of neutralization assays is recommended for vaccine evaluation.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/15808/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALvera_bongertz_etal_IOC_2012.pdfvera_bongertz_etal_IOC_2012.pdfapplication/pdf564419https://www.arca.fiocruz.br/bitstream/icict/15808/2/vera_bongertz_etal_IOC_2012.pdfb6a27b06ca31e65c79cf30ba774955dfMD52TEXTvera_bongertz_etal_IOC_2012.pdf.txtvera_bongertz_etal_IOC_2012.pdf.txtExtracted texttext/plain62648https://www.arca.fiocruz.br/bitstream/icict/15808/3/vera_bongertz_etal_IOC_2012.pdf.txt265c10de281982293816396c5de61124MD53icict/158082018-04-02 08:01:33.685oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-04-02T11:01:33Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
title International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
spellingShingle International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
Fenyö, Eva Maria
Rede Internacional
Ensaios de neutralização
HIV
International Network
The Neutnet Report
HIV Neutralization
Neutralization assays
title_short International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
title_full International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
title_fullStr International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
title_full_unstemmed International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
title_sort International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
author Fenyö, Eva Maria
author_facet Fenyö, Eva Maria
Heath, Alan
Dispinseri, Stefania
Holmes, Harvey
Lusso, Paolo
Zolla-Pazner, Susan
Donners, Helen
Heyndrickx, Leo
Alcami, Jose
Bongertz, Vera
Jassoy, Christian
Malnati, Mauro
Montefiori, David
Moog, Christiane
Morris, Lynn
Osmanov, Saladin
Polonis, Victoria
Sattentau, Quentin
Schuitemaker, Hanneke
Sutthent, Ruenpung
Wrin, Terri
Scarlatti, Gabriella
author_role author
author2 Heath, Alan
Dispinseri, Stefania
Holmes, Harvey
Lusso, Paolo
Zolla-Pazner, Susan
Donners, Helen
Heyndrickx, Leo
Alcami, Jose
Bongertz, Vera
Jassoy, Christian
Malnati, Mauro
Montefiori, David
Moog, Christiane
Morris, Lynn
Osmanov, Saladin
Polonis, Victoria
Sattentau, Quentin
Schuitemaker, Hanneke
Sutthent, Ruenpung
Wrin, Terri
Scarlatti, Gabriella
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Fenyö, Eva Maria
Heath, Alan
Dispinseri, Stefania
Holmes, Harvey
Lusso, Paolo
Zolla-Pazner, Susan
Donners, Helen
Heyndrickx, Leo
Alcami, Jose
Bongertz, Vera
Jassoy, Christian
Malnati, Mauro
Montefiori, David
Moog, Christiane
Morris, Lynn
Osmanov, Saladin
Polonis, Victoria
Sattentau, Quentin
Schuitemaker, Hanneke
Sutthent, Ruenpung
Wrin, Terri
Scarlatti, Gabriella
dc.subject.other.pt_BR.fl_str_mv Rede Internacional
Ensaios de neutralização
HIV
topic Rede Internacional
Ensaios de neutralização
HIV
International Network
The Neutnet Report
HIV Neutralization
Neutralization assays
dc.subject.en.pt_BR.fl_str_mv International Network
The Neutnet Report
HIV Neutralization
Neutralization assays
description University of Lund. Department of Microbiology, Dermatology and Infection. Lund, Sweden.
publishDate 2009
dc.date.issued.fl_str_mv 2009
dc.date.accessioned.fl_str_mv 2016-09-15T13:53:21Z
dc.date.available.fl_str_mv 2016-09-15T13:53:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv FENYÖ, Eva Maria; et al. International Network for Comparison of HIV Neutralization Assays: The NeutNet Report. Plos One, v.4, n.2, e4505, 12p, Feb. 2009.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/15808
dc.identifier.issn.pt_BR.fl_str_mv 1932-6203
dc.identifier.doi.none.fl_str_mv 10.1371/journal.pone.0004505
identifier_str_mv FENYÖ, Eva Maria; et al. International Network for Comparison of HIV Neutralization Assays: The NeutNet Report. Plos One, v.4, n.2, e4505, 12p, Feb. 2009.
1932-6203
10.1371/journal.pone.0004505
url https://www.arca.fiocruz.br/handle/icict/15808
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/15808/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/15808/2/vera_bongertz_etal_IOC_2012.pdf
https://www.arca.fiocruz.br/bitstream/icict/15808/3/vera_bongertz_etal_IOC_2012.pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
b6a27b06ca31e65c79cf30ba774955df
265c10de281982293816396c5de61124
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009162501619712